Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Avalon Pharma discloses new modulators of gene expression

Aug. 18, 2010

HemaQuest begins phase II HQK-1004 trial in EBV-related malignancies

Aug. 18, 2010

ValiRx to develop CRT's prostate cancer candidate VAL-201

Aug. 17, 2010

Merck KGaA discloses new MetAP 2 inhibitors

Aug. 17, 2010

Intellikine claims new PI3K and mTOR inhibitors

Aug. 17, 2010

Takeda discovers new PARP inhibitors

Aug. 17, 2010

FDA grants orphan drug status to BC-819 in pancreatic cancer

Aug. 16, 2010

EMA validates CTI's expanded pediatric program for pixantrone in NHL

Aug. 16, 2010

Syndax raises funds for ENCORE-301 trial in breast cancer

Aug. 16, 2010

AVEO completes enrollment in phase III tivozanib trial in renal cell carcinoma

Aug. 16, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...